NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 902.6 DKK | +2.01% |
|
+3.12% | +29.29% |
| 30/04 | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
| 30/04 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 567B | ||||||
| 664B | ||||||
| 354B | ||||||
| 330B | ||||||
| 286B | ||||||
| 234B |
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Sector Chart
